Lipids in psychiatric disorders and preventive medicine
Psychiatric disorders like mood disorders, schizophrenia, or drug addiction affect a sizeable proportion of the human population and severely compromise quality of life. Therefore, measures to prevent the manifestation, and treatments to ameliorate the symptoms, of these disorders are in high demand...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
May 2017
|
| In: |
Neuroscience & biobehavioral reviews
Year: 2017, Jahrgang: 76, Pages: 336-362 |
| ISSN: | 1873-7528 |
| DOI: | 10.1016/j.neubiorev.2016.06.002 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1016/j.neubiorev.2016.06.002 Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0149763415303353 
|
| Verfasserangaben: | Miriam Schneider, Beth Levant, Martin Reichel, Erich Gulbins, Johannes Kornhuber, Christian P. Müller |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1572483040 | ||
| 003 | DE-627 | ||
| 005 | 20230426124307.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180430s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.neubiorev.2016.06.002 |2 doi | |
| 035 | |a (DE-627)1572483040 | ||
| 035 | |a (DE-576)502483040 | ||
| 035 | |a (DE-599)BSZ502483040 | ||
| 035 | |a (OCoLC)1341007974 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schneider, Miriam |e VerfasserIn |0 (DE-588)1054411085 |0 (DE-627)791502813 |0 (DE-576)410252506 |4 aut | |
| 245 | 1 | 0 | |a Lipids in psychiatric disorders and preventive medicine |c Miriam Schneider, Beth Levant, Martin Reichel, Erich Gulbins, Johannes Kornhuber, Christian P. Müller |
| 264 | 1 | |c May 2017 | |
| 300 | |a 27 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 30.04.2018 | ||
| 520 | |a Psychiatric disorders like mood disorders, schizophrenia, or drug addiction affect a sizeable proportion of the human population and severely compromise quality of life. Therefore, measures to prevent the manifestation, and treatments to ameliorate the symptoms, of these disorders are in high demand. Brain lipids determine the localization and function of proteins in the cell membrane of neurons. Lipids may also act as neurotransmitters or other signalling molecules. The lipid composition of the brain can be influenced by nutrition, environmental factors, and by behavioural activity. Thus, lipids represent a target for preventive medicine of psychiatric disorders. Here we review how brain lipids contribute to normal behaviour and to major psychiatric disorders with the focus on phospholipids/fatty acids, sphingolipids, and endocannabinoids. Accumulating evidence suggests a crucial role for membrane forming and signalling lipids in the brain in the etiopathologies of depression, bipolar disorders, schizophrenia, and drug addiction. Lipids also represent potential preventive interventions for these psychiatric disorders by either targeted dietary supplementation or pharmacological manipulation of lipid regulating enzymes. | ||
| 650 | 4 | |a Anxiety | |
| 650 | 4 | |a Schizophrenia | |
| 650 | 4 | |a Depression | |
| 650 | 4 | |a Addiction | |
| 650 | 4 | |a Endocannabinoids | |
| 650 | 4 | |a Fatty acids | |
| 650 | 4 | |a Phospholipids | |
| 650 | 4 | |a Sphingolipids | |
| 773 | 0 | 8 | |i Enthalten in |t Neuroscience & biobehavioral reviews |d Amsterdam [u.a.] : Elsevier Science, 1978 |g 76(2017), Seite 336-362 |h Online-Ressource |w (DE-627)306588706 |w (DE-600)1498433-7 |w (DE-576)105430552 |x 1873-7528 |7 nnas |a Lipids in psychiatric disorders and preventive medicine |
| 773 | 1 | 8 | |g volume:76 |g year:2017 |g pages:336-362 |g extent:27 |a Lipids in psychiatric disorders and preventive medicine |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.neubiorev.2016.06.002 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0149763415303353 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180430 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 1054411085 |a Schneider, Miriam |m 1054411085:Schneider, Miriam |d 60000 |e 60000PS1054411085 |k 0/60000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1572483040 |e 3007618509 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 30.04.2018"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"recId":"1572483040","title":[{"title_sort":"Lipids in psychiatric disorders and preventive medicine","title":"Lipids in psychiatric disorders and preventive medicine"}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Schneider, Miriam","given":"Miriam","family":"Schneider"}],"physDesc":[{"extent":"27 S."}],"relHost":[{"title":[{"subtitle":"official journal of the International Behavioral Neuroscience Society","title":"Neuroscience & biobehavioral reviews","title_sort":"Neuroscience & biobehavioral reviews"}],"part":{"extent":"27","text":"76(2017), Seite 336-362","volume":"76","pages":"336-362","year":"2017"},"titleAlt":[{"title":"Neuroscience and biobehavioral reviews"}],"pubHistory":["2.1978 -"],"language":["eng"],"recId":"306588706","type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Lipids in psychiatric disorders and preventive medicineNeuroscience & biobehavioral reviews","note":["Gesehen am 20.02.2020"],"id":{"zdb":["1498433-7"],"eki":["306588706"],"issn":["1873-7528"]},"origin":[{"publisher":"Elsevier Science","dateIssuedKey":"1978","dateIssuedDisp":"1978-","publisherPlace":"Amsterdam [u.a.]"}],"physDesc":[{"extent":"Online-Ressource"}]}],"origin":[{"dateIssuedDisp":"May 2017","dateIssuedKey":"2017"}],"id":{"eki":["1572483040"],"doi":["10.1016/j.neubiorev.2016.06.002"]},"name":{"displayForm":["Miriam Schneider, Beth Levant, Martin Reichel, Erich Gulbins, Johannes Kornhuber, Christian P. Müller"]}} | ||
| SRT | |a SCHNEIDERMLIPIDSINPS2017 | ||